15-Sep-2026
Market Chameleon (Thu, 13-Aug 6:31 AM ET)
LENSAR Accelerates ALLY System Adoption With Record Growth in Recurring Revenue and Net Income
Market Chameleon (Thu, 13-Aug 3:29 AM ET)
LENSAR Reports Second Quarter 2026 Results and Provides Business Update
Globe Newswire (Thu, 13-Aug 7:00 AM ET)
LENSAR to Report Second Quarter 2026 Results on August 13th, 2026
Globe Newswire (Thu, 6-Aug 8:00 AM ET)
FTC Pressure Halts Alcon-LENSAR Merger — What’s Next for LNSR and the Cataract Surgery Market?
Market Chameleon (Tue, 17-Mar 4:41 AM ET)
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
Lensar trades on the NASDAQ stock market under the symbol LNSR.
As of September 15, 2026, LNSR stock price declined to $7.64 with 91,213 million shares trading.
LNSR has a beta of 1.92, meaning it tends to be more sensitive to market movements. LNSR has a correlation of 0.09 to the broad based SPY ETF.
LNSR has a market cap of $93.83 million. This is considered a Micro Cap stock.
Last quarter Lensar reported $16 million in Revenue and $.10 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.37.
In the last 3 years, LNSR traded as high as $17.31 and as low as $1.80.
The top ETF exchange traded funds that LNSR belongs to (by Net Assets): VTI, VXF, IWC, DFMC, DFAS.
LNSR has underperformed the market in the last year with a price return of -38.1% while the SPY ETF gained +15.7%. However, in the short term, LNSR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +33.6% vs +0.6% return in SPY. But in the last 2 weeks, LNSR shares have been beat by the market, returning -9.7% compared to an SPY return of -0.6%.
LNSR support price is $7.53 and resistance is $8.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LNSR shares will trade within this expected range on the day.